Cancer Treatment
Study results from University of Helsinki, Finland, in the area of cancer treatment discussed
Published in Gene Therapy Weekly, December 14th, 2006
Study 1: According to recent research published in the Journal of Cell Science, epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition (EMT) in lung carcinoma cells.
"Epilysin (MMP-28) is the newest member of the matrix metalloproteinase (MMP) family. Although it is expressed in a number of tissues, no biological substrates or functions for this enzyme have been identified yet," wrote S.A. Illman and colleagues, University of Helsinki.
"We have expressed recombinant epilysin in A549 lung adenocarcinoma...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-12-14)
More Articles from Gene Therapy Weekly
- Genetics & Genomics
Gene therapy technique to combat alpha-1 antitrypsin disorder proves safe and effective - Angiogenesis
Data from Konyang University, College of Medicine provide new insights into angiogenesis - Angiogenesis
Reports outline angiogenesis study findings from Toho University, Center of Diabetes - Colon Cancer
Researchers from Integrated Cancer Prevention Center detail findings in colon cancer - Dengue Fever
Data from Rush University advance knowledge in dengue fever - DNA Vaccines
Researchers from Huazhong Agricultural University, College of Veterinary Medicine publish findings in DNA vaccines - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
